Effectiveness of a Multicomponent Treatment Based on Pain Neuroscience Education, Therapeutic Exercise, Cognitive Behavioral Therapy, and Mindfulness in Patients With Fibromyalgia (FIBROWALK Study)

Objective. The purpose of this study was to evaluate the effectiveness of a 12-week multicomponent treatment based on pain neuroscience education, therapeutic exercise, cognitive behavioral therapy, and mindfulness-in addition to treatment as usual-compared with treatment as usual only in patients w...

ver descrição completa

Detalhes bibliográficos
Autores: Serrat López, Mayte|||0000-0002-5591-9407, Sanabria-Mazo, Juan P.|||0000-0003-1688-435X, Almirall, Míriam|||0000-0002-4874-8013, Musté, Marta|||0000-0002-0748-1121, Feliu-Soler, Albert|||0000-0003-2810-7670, Méndez Ulrich, Jorge Luis|||0000-0001-9718-0607, Sanz Ruiz, Antoni|||0000-0002-7952-4477, Luciano, Juan Vicente|||0000-0003-0750-1599
Formato: artículo
Fecha de publicación:2021
País:España
Recursos:Universitat Autònoma de Barcelona
Repositorio:Dipòsit Digital de Documents de la UAB
Idioma:inglés
OAI Identifier:oai:ddd.uab.cat:296435
Acesso em linha:https://ddd.uab.cat/record/296435
https://dx.doi.org/urn:doi:10.1093/ptj/pzab200
Access Level:acceso abierto
Palavra-chave:Cognitive behavioral therapy
Fibromyalgia
Mindfulness
Multicomponent Treatment
Pain Neuroscience Education
Therapeutic Exercise
Descrição
Resumo:Objective. The purpose of this study was to evaluate the effectiveness of a 12-week multicomponent treatment based on pain neuroscience education, therapeutic exercise, cognitive behavioral therapy, and mindfulness-in addition to treatment as usual-compared with treatment as usual only in patients with fibromyalgia. Methods. This randomized controlled trial involved a total of 272 patients who were randomly assigned to either multicomponent treatment (n = 135) or treatment as usual (n = 137). The multicomponent treatment (2-hour weekly sessions) was delivered in groups of 20 participants. Treatment as usual was mainly based on pharmacological treatment according to the predominant symptoms. Data on functional impairment using the Revised Fibromyalgia Impact Questionnaire as the primary outcome were collected as were data for pain, fatigue, kinesiophobia, physical function, anxiety, and depressive symptoms (secondary outcomes) at baseline, 12 weeks, and, for the multicomponent group only, 6 and 9 months. An intention-to-treat approach was used to analyze between-group differences. Baseline differences between responders (.